Compounds > tetradecanoylphorbol acetate
Page last updated: 2024-08-23

tetradecanoylphorbol acetate and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

tetradecanoylphorbol acetate has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elias, PM; Feingold, KR; Mao-Qiang, M; Menon, GK; Schaude, M1
Arpaia, M; Banfi, C; Mussoni, L; Sironi, L; Tremoli, E1
Bandoh, T; Hoshi, K; Inoue, M; Mitani, H; Nakashima, A; Sato, EF1
Benéteau, N; Chapuis, V; Colpaert, FC; Dupont-Passelaigue, E; Junquéro, D; Lestienne, F; Patoiseau, JF; Rival, Y; Taillandier, T1

Other Studies

4 other study(ies) available for tetradecanoylphorbol acetate and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
    The Journal of investigative dermatology, 1992, Volume: 98, Issue:2

    Topics: Alkanes; Animals; Cell Membrane Permeability; Cholesterol; Dermatitis; Epidermis; Fatty Acids, Monounsaturated; Fluvastatin; Histocytochemistry; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lanthanum; Lipase; Lovastatin; Male; Mice; Mice, Hairless; Skin; Tetradecanoylphorbol Acetate; Up-Regulation

1992
Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.
    Thrombosis and haemostasis, 2000, Volume: 84, Issue:1

    Topics: Cells, Cultured; Depression, Chemical; Diterpenes; Endothelium, Vascular; Farnesol; Fatty Acids, Monounsaturated; Fluvastatin; Gene Expression Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipopolysaccharides; Mevalonic Acid; Plasminogen Activator Inhibitor 1; RNA, Messenger; Tetradecanoylphorbol Acetate; Tissue Plasminogen Activator; Tumor Necrosis Factor-alpha; Umbilical Veins

2000
Antioxidative potential of fluvastatin via the inhibition of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity.
    Biological & pharmaceutical bulletin, 2003, Volume: 26, Issue:6

    Topics: Administration, Oral; Animals; Antioxidants; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Fatty Acids, Monounsaturated; Fluvastatin; In Vitro Techniques; Indoles; Male; NADPH Oxidases; Neutrophils; Pravastatin; Rats; Rats, Wistar; Reactive Oxygen Species; Tetradecanoylphorbol Acetate

2003
Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages.
    DNA and cell biology, 2004, Volume: 23, Issue:5

    Topics: Acetamides; Acetates; Anilides; Cardiovascular Agents; Cell Line; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fenofibrate; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipoproteins, LDL; Macrophages; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mevalonic Acid; Monocytes; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Tetradecanoylphorbol Acetate; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Transcription Factors

2004